<DOC>
	<DOCNO>NCT02183467</DOCNO>
	<brief_summary>Assessment effect BI 1356 Placebo prolongation QT interval</brief_summary>
	<brief_title>Effect BI 1356 Single Dose QT Interval Healthy Female Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Linagliptin</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Healthy male female , 21 50 year age Body mass index ( BMI ) range 18.5 29.9 kg/m2 Signed write informed consent prior admission study accordance Good Clinical Practice local legislation Any finding medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) within least one month less ten halflives respective drug enrolment study study Use drug might influence result trial 7 day prior enrolment study study Participation another trial investigational drug ( ≤ 60 day prior administration trial ) Heavy smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation ( ≥ 100 mL within four week prior administration trial ) Any deviation laboratory value consider clinical relevance Excessive physical activity within last week trial trial Hypersensitivity Moxifloxacin relate drug class Supine blood pressure screen systolic &lt; 100 mmHg diastolic &lt; 60 mmHg Heart rate screen &gt; 80 bpm &lt; 40 bpm Any screen ECG value outside reference range clinical relevance include , limited PR interval &gt; 220 m , QRS interval &gt; 115 m , QTcB QTcF &gt; 450 m , QT ( uncorrected ) &gt; 470 ms Subjects involve passenger transport operation dangerous machine For Female subject : Pregnancy positive pregnancy test , plan become pregnant study within 1 month study completion Pregnancy No adequate contraception study 1 month study completion , i.e . implant , injectables , combine oral contraceptive , IUD [ intrauterine device ] , sexual abstinence ( least 1 month prior enrolment ) , vasectomised partner ( vasectomy perform least 1 year prior enrolment ) , surgical sterilisation ( incl . hysterectomy ) . Females , vasectomise partner , sexually abstinent surgically sterile ask additionally use barrier contraception method ( e.g . condom , diaphragm spermicide ) Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>